Patent · US Active

S1P3 antagonists

US9951017B2 · kind B2 · utility

1Cited by

1References

22Claims

0Family size

Assignee

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · IL

Inventors

Chiara Caramelli · Stigliano, IT
Cesare Federico · Perugia, IT
Emanuele Gabellieri · Lausanne, CH
Matteo Magnani · Pratovecchio, IT
Iolanda Micco · Colle di Val d'Elsa, IT
Georg C. Terstappen · Battenberg, DE

Key dates

Filing date	Nov 28, 2014
Grant date	Apr 24, 2018
Priority date	—
Expiry date	Nov 28, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to antagonists of the S1P3 receptor formula (A) as herein described and pharmaceutical compositions thereof. The compounds of formula (A) are useful in the preparation of a medicament, in particular for the treatment of Alzheimer's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.